Journal Logo

June 2020 - Volume 30 - Issue 3
pp: 223-324

Basic science


The alternatively spliced RECK transcript variant 3 is a predictor of poor survival for melanoma patients being upregulated in aggressive cell lines and modulating MMP gene expression in vitro

Jacomasso, Thiago; Ribas, Hennrique Taborda; Trombetta-Lima, Marina; More

Melanoma Research. 30(3):223-234, June 2020.

Translational research


Clinical research


Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM)

Rozeman, Elisa A.; Prevoo, Warner; Meier, Mark A.J.; More

Melanoma Research. 30(3):252-260, June 2020.

Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II)

Atkinson, Victoria; Sandhu, Shahneen; Hospers, Geke; More

Melanoma Research. 30(3):261-267, June 2020.

Epidemiology of melanoma


A meta-analysis of melanoma risk in industrial workers

Vujic, Igor; Gandini, Sara; Stanganelli, Ignazio; More

Melanoma Research. 30(3):286-296, June 2020.